Abstract
Due to the increasing importance of age-related macular degeneration (AMD) in the modern western world an enormous number of scientific papers have been published concerning the epidemiology, pathogenesis, morphology, and therapy of this disease. All these articles mainly concentrated on changes of the posterior part of the retina, as AMD is a disease of the chorioretinal interface, specifically the retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. In the past, only a few studies examined the relationship of the posterior vitreous cortex and the retina and changes at the vitreo-macular interface in eyes suffering from AMD. Weber-Krause et al. conducted a study based on B-scan ultrasound and reported a higher incidence of incomplete posterior vitreous detachment (PVD) in eyes with AMD compared to age-matched controls [1]. Similarly, Ondes et al. found that complete PVD was more frequent in eyes without AMD compared to eyes with AMD [2]. Neither study specifically evaluated the vitreo-macular relationship in AMD, although it was implicit that anomalous PVD may play a role, as it does in other conditions [see chapter III.B. Anomalous PVD and vitreoschisis].
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Weber-Krause B, Eckardt C. Incidence of posterior vitreous detachment in the elderly. Ophthalmologe. 1997;94:619–23. German.
Ondes F, Yilmaz G, Acar MA, Unlu N, Kocaoglan H, Arsan AK. Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol. 2000;44(1):91–3.
Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004;45:4151–60.
Foos RY. Posterior vitreous detachment. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:480–97.
Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol. 2007;144(5):741–6. Epub 2007 Sep 20.
Robison CD, Krebs I, Binder S, Barbazetto IA, Kotsolis AI, Yannuzzi LA, Sadun AA, Sebag J. Vitreomacular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol. 2009;148:79–82.
Lee SJ, Lee CS, Koh HJ. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study. Am J Ophthalmol. 2009;147:621–6.
Krebs I, Glittenberg C, Zeiler F, Binder S. Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration. Br J Ophthalmol. 2011;95(10):1415–8.
Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–34.
Slakter JS, Yannuzzi LA, Schneider U, et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2000;107:742–53.
Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D, Matsumoto Y, Sorenson JA, Yannuzzi L. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina. 2008;28:201–11.
Mojana F, Cheng L, Bartsch DU, Silva GA, Kozak I, Nigam N, Freeman WR. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol. 2008;146:218–27.
Wang MY, Nguyen D, Hindoyan N, Sadun AA, Sebag J. Vitreo-papillary adhesion in macular hole and macular pucker. Retina. 2009;29:644–50.
Sebag J, Wang MY, Nguyen D, Sadun AA. Vitreopapillary adhesion in macular diseases. Trans Am Ophthalmol Soc. 2009;107:35–44.
Gupta P, Yee KM, Garcia P, Rosen RB, Parikh J, Hageman GS, Sadun AA, Sebag J. Vitreoschisis in macular diseases. Br J Ophthalmol. 2011;95(3):376–80. doi:10.1136/bjo.2009.175109. Epub 2010 Jun 28.
Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol. 2008;246(3):329–32. doi:10.1007/s00417-007-0743-x. Epub 2008 Jan 29.
Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, Ferris FL, Bressler SB, Milton RC, Age-Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484–98.
Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, Milton RC, Bressler SB, Klein R, Age-Related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570–4.
Waldstein SM, Sponer U, Simader C, Sacu S, Schmidt-Erfurth U. Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study. Retina. 2012;32(3):424–33.
Geck U, Pustolla N, Baraki H, Atili A, Feltgen N, Hoerauf H. Posterior vitreous detachment following intravitreal drug injection. Graefes Arch Clin Exp Ophthalmol. 2013;251(7):1691–5.
CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364(20):1897–908. Epub 2011 Apr 28.
IVAN Study Investigators, Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology. 2012;119(7):1399–411. Epub 2012 May 11.
Krebs I, Schmetterer L, Boltz A, Told R, Vécsei-Marlovits V, Egger S, Schönherr U, Haas A, Ansari-Shahrezaei S, Binder S; for the MANTA Research Group. A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. Br J Ophthalmol. 2013. 97(3):266-71.
Krebs I, Glittenberg C, Ansari-Shahrezaei S, Hagen S, Steiner I, Binder S. Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration. Br J Ophthalmol. 2013;97(11):1443–6. doi:10.1136/bjophthalmol-2013-303513. Epub 2013 Aug 21.
Lee SJ, Koh HJ. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology. 2011;118(1):101–10.
Schulze S, Hoerle S, Mennel S, Kroll P. Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol. 2008;86(5):470–81. doi:10.1111/j.1755-3768.2008.01210.x. Epub 2008 Jun 28. Review.
Simpson AR, Petrarca R, Jackson TL. Vitreomacular adhesion and neovascular age-related macular degeneration. Surv Ophthalmol. 2012;57(6):498–509. doi:10.1016/j.survophthal.2012.01.011.
Cho M, Barbazetto IA, Freund KB. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol. 2009;148(1):70–8.
Rouvas AA, Chatziralli IP, Theodossiadis PG, Moschos MM, Kotsolis AI, Ladas ID. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. Retina. 2012;32(6):1181–9. doi:10.1097/IAE.0b013e318235d8ce.
Nomura Y, Ueta T, Iriyama A, Inoue Y, Obata R, Tamaki Y, Yamaguchi T, Yanagi Y. Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmology. 2011;118(5):853–9. doi:10.1016/j.ophtha.2010.09.001. Epub 2010 Nov 20.
Roller AB, Mahajan VB, Boldt HC, Abramoff MD, Russell SR, Folk JC. Effects of vitrectomy on age-related macular degeneration. Ophthalmology. 2010;117(7):1381–6. doi:10.1016/j.ophtha.2009.11.007. Epub 2010 Feb 21.
Schulze S, Neugebauer A, Kroll P. Appearance of age-related macular degeneration in vitrectomized and nonvitrectomized eyes: an intraindividual case study. Acta Ophthalmol. 2012;90(3):244–7. doi:10.1111/j.1755-3768.2010.01929.x. Epub 2010 May 14.
Ikeda T, Sawa H, Koizumi K, Yasuhara T, Yamasaki T. Pars plana vitrectomy for regression of choroidal neovascularization with age-related macular degeneration. Acta Ophthalmol Scand. 2000;78(4):460–4.
Sakamoto T, Sheu SJ, Arimura N, Sameshima S, Shimura M, Uemura A, Kawano H, Wu TT, Kubota T, Sohma R, Noda Y. Vitrectomy for exudative age-related macular degeneration with vitreous hemorrhage. Retina. 2010;30(6):856–64. doi:10.1097/IAE.0b013e3181c969cb.
Shah SU, Haller JA. Vitreomacular traction in a case of exudative age-related macular degeneration resistant to anti-VEGF therapy. Acta Ophthalmol. 2012;90(7):e569–70. doi:10.1111/j.1755-3768.2011.02372.x. Epub 2012 Mar 16.
Schmidt JC, Mennel S, Hörle S, Meyer CH. High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy. Br J Ophthalmol. 2006;90(11):1361–2. Epub 2006 Jul 19.
Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH. Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol. 2009;247(8):1019–23. doi:10.1007/s00417-009-1072-z. Epub 2009 Apr 4.
Maeda N, Tano Y. Intraocular oxygen tension in eyes with proliferative diabetic retinopathy with and without vitreous. Graefes Arch Clin Exp Ophthalmol. 1996;234 Suppl 1:S66–9.
Stefánsson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):147–63. doi:10.1007/s00417-008-0980-7. Epub 2008 Nov 26. Review.
Sebag J. Pharmacologic vitreolysis (Guest Editorial). Retina 1998;18:1–3.
Sebag J. Pharmacologic vitreolysis - premise and promise of the first decade. Retina. 2009;29(7):871–4. doi:10.1097/IAE.0b013e3181ac7b3c.
Kim YM, Lee SJ, Koh HJ. Gas-assisted release of vitreomacular adhesion in wet age-related macular degeneration. Retina. 2011;31(10):2123–4.
Abrishami M, Moosavi MN, Shoeibi N, Hosseinpoor SS. Intravitreal tissue plasminogen activator to treat refractory diabetic macular edema by induction of posterior vitreous detachment. Retina. 2011;31(10):2065–70.
Kuppermann BD. Ocriplasmin for pharmacologic vitreolysis. Retina. 2012;32 Suppl 2:S225–8; discussion S228-31.
Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration–what is the cause? Retina. 2003;23:595–614.
Grossniklaus HE, Miskala PH, Green WR, Bressler SB, Hawkins BS, Toth C, Wilson DJ, Bressler NM. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch Ophthalmol. 2005;123(7):914–21.
Stefánsson E, Geirsdóttir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res. 2011;30(1):72–80. doi:10.1016/j.preteyeres.2010.09.003. Epub 2010 Oct 15.
Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51(2):137–52. Review.
Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina. 2007;27(8):1090–6.
Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37(9):1929–34.
Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005;25(2):111–8. Review.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Video III.G-1
VMT with CNV (virtual C-mode and RPE-fit slab). This video shows how to visualize the correlation between VMT and a CNV located immediately beneath it using the RPE-fit slab capability of the Carl Zeiss™ Cirrus HD-OCT. By creating a virtual C-mode visualization, whose contour can be adjusted to fit the contour of the RPE, it is possible to show the exact location of the CNV and its relationship to the forces of vitreo-macular traction and adhesion immediately above it (AVI 131278 kb)
Video III.G-2
VMT with no CNV (virtual C-mode and RPE-fit slab). This video shows the same method as described in Video III.G-1 used on a patient with VMT and no CNV for the sake of comparison. The same process of scrolling through the RPE-fit virtual C-mode scan reveals no CNV relating to the area of the VMT (AVI 131278 kb)
Video III.G-3
VMT with CNV (real-time interactive voxel rendering). This video shows a real-time screen-grab of the voxel rendering system in use. The system is based on a plug-in that was written for the 3D rendering and animation program Maxon™ Cinema 4D™. This system has the capability of creating real-time visualizations of segmentational data sets. It differs fundamentally from conventional visualization systems in as much as it creates ray-traced shading directly on the data set interactively. This capability greatly increases the detail and quality of the visualization (AVI 131278 kb)
Video III.G-4
VMT with CNV (voxel rendering). This video shows the same case as in Videos III.G-1 and III.G-3 visualized using a prerendered voxel visualization as described in Video III.G-3. The white arrow shows the location of the CNV under the VMT and adhesion. As can be seen in the visualization, the direction of the folds in the VMT points at the location of the CNV indicating a correlation between tractional forces and the presence of CNV (AVI 131278 kb)
Video III.G-5
VMT with CNV (real-time interactive GPU rendering). This video shows the same case as in Videos III.G-1, III.G-3, and III.G-4 visualized using a GPU-based triangle-mesh segmentation visualization system designed using CUDA algorithms and rendered on an Nvidea GTX GeForce 590 graphics card. This video shows a screen-grab of the interactive real-time capabilities of the system. The black lines show the correlation between the tractional forces of the VMT and the location of the CNV (AVI 131278 kb)
Video III.G-6
VMT with CNV (GPU rendering). This video shows the same case as in Videos III.G-1, III.G-3, III.G-4, and III.G-5 using the same visualization system described in Video III.G-5. This video is a prerendered animation (non-real time) showing the correlation between the VMT and the location of the CNV (black lines) (AVI 131278 kb)
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Krebs, I., Glittenberg, C., Binder, S. (2014). III.G. Vitreous in Age-Related Macular Degeneration. In: Sebag, J. (eds) Vitreous. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1086-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1086-1_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1085-4
Online ISBN: 978-1-4939-1086-1
eBook Packages: MedicineMedicine (R0)